Vanda Pharmaceuticals Inc (VNDA) Event Aug. 04, 2022, 00:00 UTC (99% Positive) VANDA PHARMACEUTICALS INC. (VNDA) Reports 575% Profit Growth for 2022-06-30 Full text
Register to leave comments News bot Oct. 29, 2025, 10:55 a.m. 🏢 Vanda Pharmaceuticals Inc (VNDA) - Form 10-Q Quarterly Report Quarterly financial filing submitted to the SEC 📋 Filing Information 📄 Form Type: 10-Q 📅 Filing Date: 2022-08-04 📊 Period of Report: 2022-06-30 ⏰ Accepted: N/A 📊 Key Financial Metrics (Period-over-Period Comparison) Metric Current Period Previous Period Change ($) Change (%) Trend Net Income/Loss $18.30M $-3.86M $22.16M +574.66% 📉 Total Assets $593.79M $609.10M $-15.31M -2.51% ↘️ Total Liabilities $88.86M $100.55M $-11.69M -11.62% 📈 Stockholders' Equity $481.22M $-179.03M $660.25M +368.80% 📈 Operating Income/Loss $22.71M $-4.21M $26.92M +639.69% 📉 R&D Expense $36.38M $42.46M $-6.08M -14.32% 📈 SG&A Expense $58.14M $73.85M $-15.71M -21.27% 📈 Revenues $130.57M $124.58M $5.99M +4.80% ➡️ Earningspersharebasic $0.33 $-0.07 $0.40 +571.43% 📈 Earningspersharediluted $0.32 $-0.07 $0.39 +557.14% 📈 📈 Financial Trend Analysis 💰 Profitability improved with +574.7% net income growth 📎 View Full 10-Q Filing on SEC.gov Access the complete official filing document
🏢 Vanda Pharmaceuticals Inc (VNDA) - Form 10-Q Quarterly Report
📋 Filing Information
Key Financial Metrics (Period-over-Period Comparison)
Financial Trend Analysis
💰 Profitability improved with +574.7% net income growth
📎 View Full 10-Q Filing on SEC.gov
Access the complete official filing document